<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">17484191</PMID>
      <DateCompleted>
        <Year>2007</Year>
        <Month>05</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1362-5187</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>11</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2006</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>The European journal of contraception &amp; reproductive health care : the official journal of the European Society of Contraception</Title>
          <ISOAbbreviation>Eur J Contracept Reprod Health Care</ISOAbbreviation>
        </Journal>
        <ArticleTitle>State-of-the-art of intrauterine contraception.</ArticleTitle>
        <Pagination>
          <StartPage>262</StartPage>
          <EndPage>269</EndPage>
          <MedlinePgn>262-9</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Despite its nearly 100-year history, intrauterine contraception is a modern method even in the 21st century and its development is still going on. The aim of innovations is to optimize the contraceptive efficacy and to suppress as much as possible side effects and unwanted events (e.g. menstrual irregularities, expulsion). It is important that this method be made available to all those who could not resort to it earlier (young women, nulligravidae, nulliparae). Currently three areas are more particularly being investigated: (1) flexible, frameless intrauterine implants, (2) levonorgestrel-releasing intrauterine systems, and (3) metal alloy intrauterine devices. Partly relying on the author's own clinical experience and based on the literature of recent years, this article reviews the present state and possibilities with regard to further development of intrauterine contraceptive devices.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Batár</LastName>
            <ForeName>István</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Family Planning Centre, Department of Obstetrics and Gynaecology, University of Debrecen, Debrecen, Hungary. ibatar@jaguar.dote.hu</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Eur J Contracept Reprod Health Care</MedlineTA>
        <NlmUniqueID>9712127</NlmUniqueID>
        <ISSNLinking>1362-5187</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>5W7SIA7YZW</RegistryNumber>
          <NameOfSubstance UI="D016912">Levonorgestrel</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007434" MajorTopicYN="Y">Intrauterine Devices</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007435" MajorTopicYN="N">Intrauterine Devices, Copper</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007436" MajorTopicYN="N">Intrauterine Devices, Medicated</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016912" MajorTopicYN="N">Levonorgestrel</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <NumberOfReferences>29</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2007</Year>
          <Month>5</Month>
          <Day>9</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2007</Year>
          <Month>6</Month>
          <Day>1</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2007</Year>
          <Month>5</Month>
          <Day>9</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">17484191</ArticleId>
        <ArticleId IdType="doi">10.1080/13625180600907966</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
